Maximum quantity allowed is 999
	  Please select the quantity
	
CAS RN: 1197922-04-5 | Product Number: B3970
(11bS)-2,6-Bis[bis[3,5-bis(trifluoromethyl)phenyl]hydroxymethyl]-3,5-dihydrospiro[4H-dinaphth[2,1-c:1',2'-e]azepine-4,4'-morpholinium] Bromide
![(11bS)-2,6-Bis[bis[3,5-bis(trifluoromethyl)phenyl]hydroxymethyl]-3,5-dihydrospiro[4H-dinaphth[2,1-c:1',2'-e]azepine-4,4'-morpholinium] Bromide Chemical Structure of (11bS)-2,6-Bis[bis[3,5-bis(trifluoromethyl)phenyl]hydroxymethyl]-3,5-dihydrospiro[4H-dinaphth[2,1-c:1',2'-e]azepine-4,4'-morpholinium] Bromide](/medias/B3970.jpg?context=bWFzdGVyfHJvb3R8NzQxOTd8aW1hZ2UvanBlZ3xhRGRpTDJnMVpTODRPVEl3TVRnd09URTJNalUwTDBJek9UY3dMbXB3Wnd8NjY4OTBmZjcyZjUxYzQ3N2M5MGQ0MDAyMDhhOWQ0OTJiMDU1MzIwMDExNTkzMTI2NWU1MGVkMjhhNjZiNmQ2YQ) 
									 
							Purity: >97.0%(HPLC)
Synonyms:
						
						Product Documents:
                    
				
						* Please contact our distributors or
						TCI
						to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
						* The storage conditions are subject to change without notice.
| Product Number | B3970 | 
| Purity / Analysis Method   | >97.0%(HPLC) | 
| Molecular Formula / Molecular Weight | C__6__0H__3__6BrF__2__4NO__3 = 1,354.82 | 
| Physical State (20 deg.C) | Solid | 
| Storage Temperature   | Room Temperature (Recommended in a cool and dark place, <15°C) | 
| Packaging and Container   | 50MG-Glass Bottle with Plastic Insert (View image) | 
| CAS RN | 1197922-04-5 | 
| Reaxys Registry Number | 20072701 | 
| PubChem Substance ID | 160870901 | 
Specifications
		  | Appearance | White to Light yellow powder to crystal | 
| Purity(HPLC) | min. 97.0 area% | 
| NMR | confirm to structure | 
		Properties (reference)
	 
						 GHS
						 | Pictogram |   | 
| Signal Word | Warning | 
| Hazard Statements | H315 : Causes skin irritation. H319 : Causes serious eye irritation. | 
| Precautionary Statements | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. | 
 
								 Related Laws: 
							    
						Transport Information:
							| H.S.code* | 2934.99-000 | 
			Application
		
			Asymmetric Conjugate Addition of Oxindole Derivatives
		
		
	 				References
	
	 		
			R. He, S. Shirakawa, K. Maruoka, J. Am. Chem. Soc. 2009, 131, 16620.
			PubMed Literature
		Product Articles
  		        Product Documents (Note: Some products will not have analytical charts available.)
 		Safety Data Sheet (SDS)
                	  
                      
						Please select Language.
		         
                 
        			
					The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
				     
						
						
						
							Please enter Lot Number
						
							Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
                        
				
                
	         	
                
                
    		Sample C of A
                    This is a sample C of A and may not represent a recently manufactured lot of the product.
	         	
                A sample C of A for this product is not available at this time.
Analytical Charts
					 
			  
		  
                                			
                                				        
                                						
                                						
                                						
                                							Please enter Lot Number
                                						
                                							Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
                                						
                                				
                                				
                                	         	
                                                
                                                    The requested analytical chart is not available. Sorry for the inconvenience.
![Thumbnail of (11bS)-2,6-Bis[bis[3,5-bis(trifluoromethyl)phenyl]hydroxymethyl]-3,5-dihydrospiro[4H-dinaphth[2,1-c:1',2'-e]azepine-4,4'-morpholinium] Bromide](/medias/B3970.jpg?context=bWFzdGVyfHJvb3R8MTk2MjF8aW1hZ2UvanBlZ3xhR05tTDJoaE15ODRPVE16TmpZd05ESTJNamN3TDBJek9UY3dMbXB3Wnd8YmNkMWMxNGFmZTliZGE4MmRmMzg2YjE1ZjNiZWYxYzk3NDFmNjYwODdjZGUxMTVhZDI2YTEyNTE2NzRkYmM3Mg)
![(11bS)-2,6-Bis[bis[3,5-bis(trifluoromethyl)phenyl]hydroxymethyl]-3,5-dihydrospiro[4H-dinaphth[2,1-c:1',2'-e]azepine-4,4'-morpholinium] Bromide (11bS)-2,6-Bis[bis[3,5-bis(trifluoromethyl)phenyl]hydroxymethyl]-3,5-dihydrospiro[4H-dinaphth[2,1-c:1',2'-e]azepine-4,4'-morpholinium] Bromide](/_ui/responsive/theme-tci/images/missing_product_zoom.jpg) 
       
                                